EcoDrugPlus

Ensembl ID : ENSMAMG00000028472
Gene Symbol: -
Cross references: -
389 Possible Orthologues:

Ensembl ID : ENSMAMG00000018015
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSMAMG00000021307
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSMAMG00000012136
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSMAMG00000004868
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSMAMG00000009665
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSMAMG00000006128
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSMAMG00000005947
Gene Symbol: -
Cross references: -
379 Possible Orthologues:

Ensembl ID : ENSMAMG00000017503
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSMAMG00000017494
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSMAMG00000017480
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSMAMG00000005893
Gene Symbol: -
Cross references: -
343 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).